Get the Stockscreener App
2.64
4.76%
0.12
After Hours:
2.61
-0.03
-1.14%
Novabridge Biosciences Adr stock is traded at $2.64, with a volume of 886.63K.
It is up +4.76% in the last 24 hours and down -19.51% over the past month.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
See More
Previous Close:
$2.52
Open:
$2.53
24h Volume:
886.63K
Relative Volume:
1.16
Market Cap:
$304.37M
Revenue:
$1.10M
Net Income/Loss:
$-50.29M
P/E Ratio:
-3.6677
EPS:
-0.7198
Net Cash Flow:
-
1W Performance:
-6.38%
1M Performance:
-19.51%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.52
$2.77
1-Week Range:
$2.44
$2.77
52-Week Range:
$2.44
$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Name
Novabridge Biosciences Adr
Sector
Industry
Phone
-
Address
-
Compare NBP vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
2.64 | 290.53M | 1.10M | -50.29M | 0 | -0.7198 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-26 | Resumed | H.C. Wainwright | Buy |
| Oct-03-25 | Initiated | Leerink Partners | Outperform |
| Sep-09-25 | Initiated | BTIG Research | Buy |
| Dec-09-21 | Initiated | Siebert Williams Shank | Buy |
| Jun-02-21 | Initiated | Daiwa Securities | Buy |
| Mar-15-21 | Initiated | Needham | Buy |
| Mar-03-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-25-21 | Initiated | Piper Sandler | Overweight |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-20 | Initiated | China Renaissance | Buy |
| Feb-11-20 | Initiated | Jefferies | Buy |
View All
Novabridge Biosciences Adr Stock (NBP) Latest News
H.C. Wainwright reiterates NovaBridge stock rating on FDA feedback - Investing.com India
NovaBridge to present Phase 2a data for wet AMD treatment VIS-101 - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study By Investing.com - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study - Investing.com
NovaBridge Biosciences stock price target raised to $9 by H.C. Wainwright - Investing.com Nigeria
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NovaBridge chairman to purchase up to $5 million in company shares By Investing.com - Investing.com Nigeria
NovaBridge chairman to purchase up to $5 million in company shares - Investing.com
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target By Investing.com - Investing.com South Africa
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target - Investing.com Nigeria
NovaBridge stock soars after positive gastric cancer drug results - Investing.com
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - GlobeNewswire Inc.
Understanding RRC’s financial ratios: A beginner’s guide - uspostnews.com
NovaBridge Biosciences. ADR’s results are impressive - uspostnews.com
Faraday Future Intelligent Electric Inc (FFAI) looking to reclaim success with recent performance - setenews.com
NovaBridge to present extended dosing data for cancer drug ragistomig - Investing.com
Are Smart Investors Making the Right Decision? NovaBridge Biosciences. ADR (NBP) - Setenews
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating - Investing.com
What is the current Price Target and Forecast for NovaBridge Biosciences (NBP) - Zacks Investment Research
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India
Investors in cash trouble should check out NovaBridge Biosciences. ADR (NBP) - Setenews
Get in on Motorsport Games Inc’s (MSGM) buy-in window today! - Setenews
NovaBridge Biosciences Share Price ADS SPON - Hargreaves Lansdown
This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com
There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
symbol__ Stock Quote Price and Forecast - CNN
NovaBridge Biosciences Sponsored ADR Earnings and Revenue – NASDAQ:NBP - TradingView — Track All Markets
Long term debt to total assets ratio of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com
IMAB Stock Price, Quote & Chart | I-MAB-SPONSORED ADR (NASDAQ:IMAB) - ChartMill
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga
Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Novabridge Biosciences Adr Stock (NBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):